Loading…
image

Report Scope & Overview:

Insulin Delivery Pens Market size was valued at USD 12.5 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2030.

Insulin Delivery Pens Market Overview:
Global Insulin Delivery Pens Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Insulin Delivery Pens Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
 
Overall, Insulin Delivery Pens market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Insulin Delivery Pens market research is expected to experience further growth and innovation in the coming years.

DESCIMG1

Insulin Delivery Pens Market Key Trends

Shift towards Convenience and Ease of Use: Insulin delivery pens are gaining popularity due to their user-friendly design, ease of use, and convenience. These pens offer a discreet and portable option for insulin administration, eliminating the need for vials and syringes, and allowing for precise dosage delivery.

Rising Preference for Self-Management: With the increasing prevalence of diabetes and the emphasis on self-management, insulin delivery pens empower individuals to take control of their insulin administration. The pens offer a convenient and discreet way for patients to administer insulin injections at home or on-the-go, promoting independence and flexibility.

Technological Advancements: Insulin delivery pens are incorporating technological advancements to enhance user experience and improve treatment outcomes. These advancements include features such as memory function to record dosage history, dose adjustment options, Bluetooth connectivity for data tracking, and reminders for insulin administration.

Customization and Personalization: Insulin delivery pens are being designed to cater to individual patient needs and preferences. Manufacturers are offering pens with adjustable dosing options, different color choices, and ergonomic designs to enhance patient comfort and satisfaction.

Focus on Needle Safety and Reduction of Needle Anxiety: Needle anxiety is a common concern for individuals requiring insulin injections. Insulin delivery pens are incorporating features to address this, such as ultra-fine needles for minimized pain and anxiety, needle retraction mechanisms for safety after injection, and compatibility with pen needles of different lengths and gauges.

Increased Adoption of Disposable Pens: Disposable insulin delivery pens are witnessing significant growth due to their convenience and ease of use. These pre-filled pens eliminate the need for cartridge replacement, simplifying the insulin administration process and reducing the risk of errors.

Growing Demand for Smart Insulin Pens: Smart insulin pens, equipped with electronic components and connectivity features, are gaining traction. These pens offer capabilities such as dose tracking, reminders, glucose monitoring integration, and data sharing with healthcare providers, enabling better diabetes management and treatment adherence.

Focus on Precision and Accuracy: Insulin delivery pens are being developed to ensure precise and accurate dosage delivery, minimizing the risk of dosage errors. Improved mechanisms for dose measurement, audible click feedback, and dose confirmation features contribute to enhanced precision and reliability.

Increasing Adoption of Disposable Pen Needles: The market for disposable pen needles, used in conjunction with insulin delivery pens, is growing. Disposable pen needles offer ease of use, reduced risk of needle reuse, and improved injection comfort, promoting better insulin administration practices.

Expansion in Emerging Markets: The insulin delivery pens market is expanding in emerging markets, driven by factors such as increasing diabetes prevalence, improving healthcare infrastructure, and growing awareness about advanced diabetes management tools. Emerging markets present significant growth opportunities for manufacturers.

Sustainability and Environmental Considerations: Manufacturers are focusing on sustainability and environmental considerations by developing eco-friendly insulin delivery pens. These pens may incorporate recyclable materials, reduced plastic usage, and environmentally conscious manufacturing processes to minimize their carbon footprint.

Patient Education and Training: Efforts are being made to enhance patient education and training on insulin delivery pen usage. Healthcare providers and manufacturers are offering resources, educational programs, and training materials to ensure proper usage, dosage accuracy, and injection technique, ultimately improving patient outcomes.


Market Segmentations:

Global Insulin Delivery Pens Market: By Company
• Novo Nordisk
• Sanofi Diabetes
• Medtronic
• BD
• Animas
• Roche
• Insulet
• Bomtech
• BioSampling
• Cardiocomm Solutions
• Henke-Sass
• Kavo
• Megasan Medical
• Nipro
• Mika Medical
• Rudolf Riester
• Smiths Medical

Global Insulin Delivery Pens Market: By Type
• Reusable Insulin Pens
• Disposable Insulin Pens

Global Insulin Delivery Pens Market: By Application
• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Diabetes Clinics

Global Insulin Delivery Pens Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Insulin Delivery Pens market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Report Attribute/MetricDetails
Market Size 2022USD 12.5 billion
Compound Annual Growth Rate (CAGR)7.4%(2023-2030)
Base Year2022
Forecast Period2023-2032
Historical Data2018-2022
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Reusable Insulin Pens
• Disposable Insulin Pens
By Application• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Diabetes Clinics

Key Companies Profiled• Novo Nordisk
• Sanofi Diabetes
• Medtronic
• BD
• Animas
• Roche
• Insulet
• Bomtech
• BioSampling
• Cardiocomm Solutions
• Henke-Sass
• Kavo
• Megasan Medical
• Nipro
• Mika Medical
• Rudolf Riester
• Smiths Medical

Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request

Reasons to Purchase Insulin Delivery Pens Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.

Objectives of Insulin Delivery Pens Market Study:
The objectives of Insulin Delivery Pens market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Insulin Delivery Pens market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Insulin Delivery Pens market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.

Frequently Asked Questions

  The insulin delivery pens market refers to the industry that produces, distributes, and sells devices used for administering insulin injections. These devices, known as insulin pens, provide a convenient and user-friendly method for insulin delivery to individuals with diabetes.

  Key trends in the insulin delivery pens market include a shift towards convenience and ease of use, rising preference for self-management, technological advancements, customization and personalization, focus on needle safety and reduction of needle anxiety, increased adoption of disposable pens, growing demand for smart insulin pens, focus on precision and accuracy, expansion in emerging markets, sustainability and environmental considerations, and patient education and training.

  Technological advancements in insulin delivery pens include features such as memory function to record dosage history, dose adjustment options, Bluetooth connectivity for data tracking, and reminders for insulin administration. Smart insulin pens with electronic components and connectivity features are also being developed.

  Smart insulin pens, equipped with electronic components and connectivity features, offer capabilities such as dose tracking, reminders, glucose monitoring integration, and data sharing with healthcare providers. These pens enable better diabetes management and treatment adherence.

TABLE OF CONTENT

1 Insulin Delivery Pens Market Overview
1.1 Product Overview and Scope of Insulin Delivery Pens
1.2 Insulin Delivery Pens Segment by Type
1.2.1 Global Insulin Delivery Pens Market Value Comparison by Type (2023-2029)
1.2.2 Reusable Insulin Pens
1.2.3 Disposable Insulin Pens
1.3 Insulin Delivery Pens Segment by Application
1.3.1 Global Insulin Delivery Pens Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Diabetes Clinics
1.4 Global Insulin Delivery Pens Market Size Estimates and Forecasts
1.4.1 Global Insulin Delivery Pens Revenue 2017-2032
1.4.2 Global Insulin Delivery Pens Sales 2017-2032
1.4.3 Global Insulin Delivery Pens Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Insulin Delivery Pens Market Competition by Manufacturers
2.1 Global Insulin Delivery Pens Sales Market Share by Manufacturers (2017-2023)
2.2 Global Insulin Delivery Pens Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Insulin Delivery Pens Average Price by Manufacturers (2017-2023)
2.4 Global Insulin Delivery Pens Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Insulin Delivery Pens, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Delivery Pens, Product Type & Application
2.7 Insulin Delivery Pens Market Competitive Situation and Trends
2.7.1 Insulin Delivery Pens Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Delivery Pens Players Market Share by Revenue
2.7.3 Global Insulin Delivery Pens Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Delivery Pens Retrospective Market Scenario by Region
3.1 Global Insulin Delivery Pens Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Insulin Delivery Pens Global Insulin Delivery Pens Sales by Region: 2017-2032
3.2.1 Global Insulin Delivery Pens Sales by Region: 2017-2023
3.2.2 Global Insulin Delivery Pens Sales by Region: 2023-2032
3.3 Global Insulin Delivery Pens Global Insulin Delivery Pens Revenue by Region: 2017-2032
3.3.1 Global Insulin Delivery Pens Revenue by Region: 2017-2023
3.3.2 Global Insulin Delivery Pens Revenue by Region: 2023-2032
3.4 North America Insulin Delivery Pens Market Facts & Figures by Country
3.4.1 North America Insulin Delivery Pens Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Insulin Delivery Pens Sales by Country (2017-2032)
3.4.3 North America Insulin Delivery Pens Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Delivery Pens Market Facts & Figures by Country
3.5.1 Europe Insulin Delivery Pens Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Insulin Delivery Pens Sales by Country (2017-2032)
3.5.3 Europe Insulin Delivery Pens Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Delivery Pens Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Delivery Pens Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Insulin Delivery Pens Sales by Country (2017-2032)
3.6.3 Asia Pacific Insulin Delivery Pens Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Delivery Pens Market Facts & Figures by Country
3.7.1 Latin America Insulin Delivery Pens Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Insulin Delivery Pens Sales by Country (2017-2032)
3.7.3 Latin America Insulin Delivery Pens Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Delivery Pens Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Delivery Pens Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Insulin Delivery Pens Sales by Country (2017-2032)
3.8.3 Middle East and Africa Insulin Delivery Pens Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Delivery Pens Sales by Type (2017-2032)
4.1.1 Global Insulin Delivery Pens Sales by Type (2017-2023)
4.1.2 Global Insulin Delivery Pens Sales by Type (2023-2032)
4.1.3 Global Insulin Delivery Pens Sales Market Share by Type (2017-2032)
4.2 Global Insulin Delivery Pens Revenue by Type (2017-2032)
4.2.1 Global Insulin Delivery Pens Revenue by Type (2017-2023)
4.2.2 Global Insulin Delivery Pens Revenue by Type (2023-2032)
4.2.3 Global Insulin Delivery Pens Revenue Market Share by Type (2017-2032)
4.3 Global Insulin Delivery Pens Price by Type (2017-2032)
5 Segment by Application
5.1 Global Insulin Delivery Pens Sales by Application (2017-2032)
5.1.1 Global Insulin Delivery Pens Sales by Application (2017-2023)
5.1.2 Global Insulin Delivery Pens Sales by Application (2023-2032)
5.1.3 Global Insulin Delivery Pens Sales Market Share by Application (2017-2032)
5.2 Global Insulin Delivery Pens Revenue by Application (2017-2032)
5.2.1 Global Insulin Delivery Pens Revenue by Application (2017-2023)
5.2.2 Global Insulin Delivery Pens Revenue by Application (2023-2032)
5.2.3 Global Insulin Delivery Pens Revenue Market Share by Application (2017-2032)
5.3 Global Insulin Delivery Pens Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Novo Nordisk Insulin Delivery Pens Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi Diabetes
6.2.1 Sanofi Diabetes Corporation Information
6.2.2 Sanofi Diabetes Description and Business Overview
6.2.3 Sanofi Diabetes Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Sanofi Diabetes Insulin Delivery Pens Product Portfolio
6.2.5 Sanofi Diabetes Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Medtronic Insulin Delivery Pens Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.4.4 BD Insulin Delivery Pens Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Animas
6.5.1 Animas Corporation Information
6.5.2 Animas Description and Business Overview
6.5.3 Animas Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Animas Insulin Delivery Pens Product Portfolio
6.5.5 Animas Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Roche Insulin Delivery Pens Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Insulet
6.6.1 Insulet Corporation Information
6.6.2 Insulet Description and Business Overview
6.6.3 Insulet Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Insulet Insulin Delivery Pens Product Portfolio
6.7.5 Insulet Recent Developments/Updates
6.8 Bomtech
6.8.1 Bomtech Corporation Information
6.8.2 Bomtech Description and Business Overview
6.8.3 Bomtech Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Bomtech Insulin Delivery Pens Product Portfolio
6.8.5 Bomtech Recent Developments/Updates
6.9 BioSampling
6.9.1 BioSampling Corporation Information
6.9.2 BioSampling Description and Business Overview
6.9.3 BioSampling Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.9.4 BioSampling Insulin Delivery Pens Product Portfolio
6.9.5 BioSampling Recent Developments/Updates
6.10 Cardiocomm Solutions
6.10.1 Cardiocomm Solutions Corporation Information
6.10.2 Cardiocomm Solutions Description and Business Overview
6.10.3 Cardiocomm Solutions Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Cardiocomm Solutions Insulin Delivery Pens Product Portfolio
6.10.5 Cardiocomm Solutions Recent Developments/Updates
6.11 Henke-Sass
6.11.1 Henke-Sass Corporation Information
6.11.2 Henke-Sass Insulin Delivery Pens Description and Business Overview
6.11.3 Henke-Sass Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.11.4 Henke-Sass Insulin Delivery Pens Product Portfolio
6.11.5 Henke-Sass Recent Developments/Updates
6.12 Kavo
6.12.1 Kavo Corporation Information
6.12.2 Kavo Insulin Delivery Pens Description and Business Overview
6.12.3 Kavo Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Kavo Insulin Delivery Pens Product Portfolio
6.12.5 Kavo Recent Developments/Updates
6.13 Megasan Medical
6.13.1 Megasan Medical Corporation Information
6.13.2 Megasan Medical Insulin Delivery Pens Description and Business Overview
6.13.3 Megasan Medical Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Megasan Medical Insulin Delivery Pens Product Portfolio
6.13.5 Megasan Medical Recent Developments/Updates
6.14 Nipro
6.14.1 Nipro Corporation Information
6.14.2 Nipro Insulin Delivery Pens Description and Business Overview
6.14.3 Nipro Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Nipro Insulin Delivery Pens Product Portfolio
6.14.5 Nipro Recent Developments/Updates
6.15 Mika Medical
6.15.1 Mika Medical Corporation Information
6.15.2 Mika Medical Insulin Delivery Pens Description and Business Overview
6.15.3 Mika Medical Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Mika Medical Insulin Delivery Pens Product Portfolio
6.15.5 Mika Medical Recent Developments/Updates
6.16 Rudolf Riester
6.16.1 Rudolf Riester Corporation Information
6.16.2 Rudolf Riester Insulin Delivery Pens Description and Business Overview
6.16.3 Rudolf Riester Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.16.4 Rudolf Riester Insulin Delivery Pens Product Portfolio
6.16.5 Rudolf Riester Recent Developments/Updates
6.17 Smiths Medical
6.17.1 Smiths Medical Corporation Information
6.17.2 Smiths Medical Insulin Delivery Pens Description and Business Overview
6.17.3 Smiths Medical Insulin Delivery Pens Sales, Revenue and Gross Margin (2017-2023)
6.17.4 Smiths Medical Insulin Delivery Pens Product Portfolio
6.17.5 Smiths Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Delivery Pens Industry Chain Analysis
7.2 Insulin Delivery Pens Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Delivery Pens Production Mode & Process
7.4 Insulin Delivery Pens Sales and Marketing
7.4.1 Insulin Delivery Pens Sales Channels
7.4.2 Insulin Delivery Pens Distributors
7.5 Insulin Delivery Pens Customers
8 Insulin Delivery Pens Market Dynamics
8.1 Insulin Delivery Pens Industry Trends
8.2 Insulin Delivery Pens Market Drivers
8.3 Insulin Delivery Pens Market Challenges
8.4 Insulin Delivery Pens Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Novo Nordisk
Sanofi Diabetes
Medtronic
BD
Animas
Roche
Insulet
Bomtech
BioSampling
Cardiocomm Solutions
Henke-Sass
Kavo
Megasan Medical
Nipro
Mika Medical
Rudolf Riester
Smiths Medical

Request Sample